Fujifilm Diosynth Biotechnologies U.S.A (FDBU) has signed an interest purchase agreement with the owners of Kalon Biotherapeutics, which at closing in a few months' time will give FDBU initial 49% ownership of the College Station, Texas-based operation, and rights to appoint a majority of its board.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?